Search Details

Word: genentech (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...probably guessed, TNX-901 is an anti-IgE antibody. Here's where the business complications come in. Three companies--Genentech, Tanox and Novartis--have been working in partnership since 1996 to develop anti-IgE therapies. Their lead anti-IgE product, called Xolair, could be approved for the treatment of allergic asthma by the Food and Drug Administration as early as this summer. When Tanox decided to develop TNX-901 on its own, Genentech and Novartis objected, saying that would dilute their development efforts. Last October arbitrators ruled that Tanox cannot be the sole developer of TNX-901, leaving what looks...

Author: /time Magazine | Title: Health: Fighting over Peanuts | 3/24/2003 | See Source »

...Geneva-based company had doubts about the succession, those doubts quickly disappeared. Under the younger Bertarelli's leadership, Serono has shifted its focus from pharmaceuticals to biotechnology and almost doubled its revenues to $1.5 billion in 2002, making it the world's third largest biotech company after Amgen and Genentech. "My father created a platform, and I launched myself from it," says Bertarelli, now 37. The stake he holds together with his mother and sister is worth about $4.4 billion, placing the Bertarellis among Europe's wealthiest families--and providing Ernesto with more than enough to fund his sailing ambitions...

Author: /time Magazine | Title: Putting On Heirs | 3/24/2003 | See Source »

Boyer and Robert Swanson found Genentech, the world's first genetic-engineering company...

Author: /time Magazine | Title: The Chain Of Events | 2/17/2003 | See Source »

...Genentech scientists help clone the gene for human insulin...

Author: /time Magazine | Title: The Chain Of Events | 2/17/2003 | See Source »

Counting experience over ambition, Potter spent her early career making lateral moves and rejecting promotion offers. In 1982 she visited Genentech's South San Francisco offices to interview for a lowly sales position. She didn't get it, went to Merck and never looked back--until two years ago, when Genentech wooed her with a million-dollar bonus...

Author: /time Magazine | Title: Myrtle Potter: COO of Genentech | 12/2/2002 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | Next